SRNEQ
Price
$0.31
Change
-$0.00 (-0.00%)
Updated
Feb 22, 6:59 PM EST
89 days until earnings call
TPST
Price
$3.52
Change
+$0.19 (+5.71%)
Updated
Nov 30, 6:59 PM EST
116 days until earnings call
Ad is loading...

Compare trend and price SRNEQ vs TPST

Header iconSRNEQ vs TPST Comparison
Open Charts SRNEQ vs TPSTBanner chart's image
Sorrento Therapeutics
Price$0.31
Change-$0.00 (-0.00%)
Volume$77.42M
CapitalizationN/A
Tempest Therapeutics
Price$3.52
Change+$0.19 (+5.71%)
Volume$786.56K
CapitalizationN/A
View a ticker or compare two or three
SRNEQ vs TPST Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
SRNEQ vs. TPST commentary
Dec 01, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRNEQ is a Sell and TPST is a Hold.

COMPARISON
Comparison
Dec 01, 2023
Stock price -- (SRNEQ: $0.05 vs. TPST: $3.52)
Brand notoriety: SRNEQ: Notable vs. TPST: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SRNEQ: 76% vs. TPST: 6%
Market capitalization -- SRNEQ: $179.17M vs. TPST: $72.56M
SRNEQ [@Biotechnology] is valued at $179.17M. TPST’s [@Biotechnology] market capitalization is $72.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRNEQ’s FA Score shows that 1 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • SRNEQ’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, both SRNEQ and TPST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRNEQ’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • SRNEQ’s TA Score: 4 bullish, 3 bearish.
  • TPST’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, SRNEQ is a better buy in the short-term than TPST.

Price Growth

SRNEQ (@Biotechnology) experienced а -1.88% price change this week, while TPST (@Biotechnology) price change was -16.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.35%. For the same industry, the average monthly price growth was +26.89%, and the average quarterly price growth was +20.28%.

Reported Earning Dates

SRNEQ is expected to report earnings on Feb 28, 2024.

TPST is expected to report earnings on Mar 26, 2024.

Industries' Descriptions

@Biotechnology (+2.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for SRNEQ with price predictions.
OPEN
A.I.dvisor published
a Summary for TPST with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SRNEQ($179M) has a higher market cap than TPST($72.6M). TPST YTD gains are higher at: 205.652 vs. SRNEQ (-94.684). TPST has higher annual earnings (EBITDA): -29.09M vs. SRNEQ (-645.56M). SRNEQ has more cash in the bank: 50.3M vs. TPST (11.1M). TPST has less debt than SRNEQ: TPST (21M) vs SRNEQ (170M). SRNEQ has higher revenues than TPST: SRNEQ (60.7M) vs TPST (0).
SRNEQTPSTSRNEQ / TPST
Capitalization179M72.6M247%
EBITDA-645.56M-29.09M2,219%
Gain YTD-94.684205.652-46%
P/E RatioN/A0.20-
Revenue60.7M0-
Total Cash50.3M11.1M453%
Total Debt170M21M810%
FUNDAMENTALS RATINGS
SRNEQ vs TPST: Fundamental Ratings
SRNEQ
TPST
OUTLOOK RATING
1..100
5047
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9734
P/E GROWTH RATING
1..100
10085
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRNEQ's Valuation (27) in the Biotechnology industry is somewhat better than the same rating for TPST (69) in the Pharmaceuticals Major industry. This means that SRNEQ’s stock grew somewhat faster than TPST’s over the last 12 months.

SRNEQ's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that SRNEQ’s stock grew similarly to TPST’s over the last 12 months.

SRNEQ's SMR Rating (100) in the Biotechnology industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that SRNEQ’s stock grew similarly to TPST’s over the last 12 months.

TPST's Price Growth Rating (34) in the Pharmaceuticals Major industry is somewhat better than the same rating for SRNEQ (97) in the Biotechnology industry. This means that TPST’s stock grew somewhat faster than SRNEQ’s over the last 12 months.

TPST's P/E Growth Rating (85) in the Pharmaceuticals Major industry is in the same range as SRNEQ (100) in the Biotechnology industry. This means that TPST’s stock grew similarly to SRNEQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRNEQTPST
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGESY43.20N/A
N/A
ageas SA/NV
IMBBY23.51N/A
N/A
Imperial Brands PLC
DSVSF0.65N/A
N/A
Discovery Silver Corp.
SIVBQ0.01N/A
N/A
SVB Financial Group
ABBNY38.95N/A
N/A
ABB Ltd.

SRNEQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRNEQ has been closely correlated with SGMO. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if SRNEQ jumps, then SGMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRNEQ
1D Price
Change %
SRNEQ100%
N/A
SGMO - SRNEQ
73%
Closely correlated
+4.57%
GTHX - SRNEQ
64%
Loosely correlated
+10.59%
AGEN - SRNEQ
63%
Loosely correlated
+10.92%
CHRS - SRNEQ
60%
Loosely correlated
-2.06%
TECH - SRNEQ
57%
Loosely correlated
-0.35%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been closely correlated with MTNB. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if TPST jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
+5.56%
MTNB - TPST
73%
Closely correlated
+4.30%
ICPT - TPST
58%
Loosely correlated
N/A
PHIO - TPST
57%
Loosely correlated
+11.69%
SRNEQ - TPST
32%
Poorly correlated
N/A
ORMP - TPST
30%
Poorly correlated
+0.91%
More